Skip to Content

'
Katherine M.W. Pisters, M.D., F.A.C.P.

Present Title & Affiliation

Primary Appointment

Professor, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
Associate Program Director, Medical Oncology/Hematology Fellowship, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
Department of Thoracic Head and Neck Medical Oncology
1400 Holcombe Blvd., Unit 432
Unit Number: Unit 432
Houston, TX 77030
Room Number: FC9.2042

Education & Training

Postgraduate Training

1989-1990 Chief Medical Resident, Memorial Sloan-Kettering Cancer Center, New York, NY
1988-1991 Clinical Fellowship, Memorial Sloan-Kettering Cancer Center, New York, NY
1986-1988 Clinical Residency, Internal Medicine, The Cornell Hospitals, North Shore University Hospital & Memorial Hospital, New York, NY
1985-1986 Clinical Internship, The Cornell Hospitals, North Shore University Hospital & Memorial Hospital, New York, NY

Board Certifications

2002 American Board of Internal Medicine/Medical Oncolo
1988 American Board of Internal Medicine

Experience/Service

Academic Appointments

Internist, Department of Thoracic/Head and Neck Medical Oncology, Division of Cancer Medicine, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2005-present

Selected Publications

Invited Articles

1. Johnson, FM, Kurie JM, Peeples BO, Pisters KM, Fossella FV, Papadimitrakopoulou VA, Blumenschein GR, Komaki R, Glisson BS. Dose-Dense Therapy With a Novel Irinotecan Regimen for Small-Cell Lung Cancer. . Oncology (Williston Park) 17(7):17-21, 2003. PMID: 12886869.
2. Pisters KMW. Stage I/II non-small cell lung cancer: Is there a role for combined-modality therapy? . ASCO 2002 Educational Book:465-470, 2002.
3. Pisters KMW. Adjuvant and neoadjuvant therapy for early stage non-small cell lung cancer. Semin Oncol 28(14):23-28, 2001.
4. Pisters KMW. Adjuvant and neoadjuvant therapy for early-stage non-small cell lung cancer. Sem Oncol 28(4):23-28, 2001.
5. Pisters KMW. Adjuvant therapy after definitive surgery. Lung Cancer 34(1), 2001.
6. Pisters KMW. Editorial on adjuvant chemotherapy. . Hematology & Oncology, 2001.
7. Pisters KMW. Neoadjuvant therapy for early stage lung cancer. . The Society of Thoracic Surgeons, 2001.
8. Pisters KMW. Adjuvant systemic and local therapy in the postoperative setting: Is there benefit? . ASCO 2000 Clinical Practice Forum Book:3-7, 2000.
9. Pisters KMW. Induction chemotherapy for early-stage lung cancer. . Lung Cancer 29(2):126, 2000.
10. Pisters KMW. The role of chemotherapy in early stage (stage I and II) resectable non-small cell lung cancer. . Semin Radiat Oncol 10(4):274-279, 2000.
11. Pisters KMW . Combined modality therapy for Lung Cancer. . Medscape Oncology Conference Summaries, 5/1999.
12. Pisters KMW . Early stage NSCLC: Updates on Management and therapy. Medscape Oncology Conference Summaries, 5/1999.
13. Swisher, SG, Roth JA, Lawrence DD, Kemp BL, El-Naggar AK, Cristiano JR, Fang B, Glisson BS, Hong WK, Khuri FR, Kurie JM, Lee JJ, Lee JS, Merritt JA, Mukhopadhyay T, Nesbitt JC, Perez-Soler R, Pisters KMW, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy in oncology: Clinical challenges, needs and prospects, as reflected in p53 gene replacement in NSCLC. . Sem Oncol, 1999.
14. Pisters KMW. Phase III Intergroup trial: Induction paclitaxel/carboplatin chemotherapy followed by surgery vs. surgery only in early-stage non-small cell lung cancer. . Thoracic Oncology Newsletter, 1999.
15. Pisters KMW . Diagnosis and prognosis of lung cancer and mesothelioma. Clinical Care Options for Oncology Conference Summaries, 5/1998.
16. Pisters KMW. NSCLC trials involving thoracic surgery. . Clinical Care Options for Oncology Conference Summaries,, 5/1998.
17. Pisters KMW. BLOT Trial: Phase II trial of induction paclitaxel/carboplatin in clinical stage IB (T2N0), II (T1-2N1, T3N0) and selected IIIA (T3N1) non-small cell lung cancer. Current Clinical Trials in Thoracic Oncology, 1998.
18. Roth, JA, Swisher SG, Merritt JA, Lawrence DD, Kemp BL, Carrasco CH, El-Naggar EK, Fossella FV, Glisson BS, Hong WK, Khuri FR, Kurie JM, Nesbitt JC, Pisters KMW, Putnam JB, Schrump DS, Shin DM, Walsh GL. Gene therapy for non-small cell lung cancer: A preliminary report of a phase I trial of adenoviral p53 gene replacement. . Semin Oncol 25(8):33-337, 1998.
19. Kris, MG, Pizzo BA, Pisters KMW. Delayed emesis following cisplatin: Progress and prospects. Pharmacy and Therapeutics 22(7S):12S-17S, 1997.
20. Pisters, KMW, Ginsberg RJ. Induction chemotherapy for early stage lung cancer. Adv Oncol 13:25-29, 1997.
21. Pisters, KMW, Kris MG, Bunn PA, Jr, Johnson DH, Ruckdeschel JC, Crowley JJ, Ginsberg RJ,. Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Sem Oncol 24(12):S12-41/S12-44, 1997.
22. Pisters KMW. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 11:44,49, 1997.
23. Lee, JS, Pisters KMW, Komaki R, Glisson BS, Khuri FR, Schea R, Fossella FV. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: A preliminary report. Sem Oncol 24(12):S12-52/S12-55, 1997.
24. Kris, MG, Pisters KMW, Ginsberg RJ, Rigas JR, Miller VA, Grant SC, Gralla RJ, Heelan RT, Martini N. Effectiveness and toxicity of preoperative therapy in Stage IIIA non-small cell lung cancer including the Memorial Sloan-Kettering experience with induction MVP in patients with bulky mediastinal lymph node metastases (Clinical N2). Lung Cancer 12(1):S47-S57, 1995.
25. Kris, MG, Pisters KMW, Hinkley L. Delayed emesis following anticancer chemotherapy. Support Care Cancer 2:297-300, 1994.
26. Pisters, KMW, Kris MG. Granisetron to prevent vomiting after cancer chemotherapy. Medical Letter, 1994.
27. Kris, MG, Baltzer L, Hinkley L, Pisters KMW. Strategies to control vomiting caused by anticancer drugs. . Adv Biosciences 91:391-397, 1994.
28. Pisters, KMW, Kris MG. Drugs for nausea caused by cancer chemotherapy. Medical Letter 35(912):124-126, 1993.
29. Kris, MG, Martini N, Gralla RJ, Pisters KMW, Heelan RT. Primary chemotherapy in stage IIIA non-small cell lung cancer patients with clinically apparent mediastinal lymph node metastases: Focus on five-year survivors. Lung Cancer 9:369-376, 1993.

Editorials

1. Pisters KM. Postoperative adjuvant chemotherapy for stage IB NSCLC. Abstracts in Hematology & Oncology 10(2):3-5, 2007.
2. Pisters KMW, Darling G. The IASLC Lung Cancer Staging Project: “The Nodal Zone”. J Thorac Oncol 2(7):583-584, 2007.
3. Pisters KM. Editorial on adjuvant chemotherapy. Abstracts in Hematology & Oncology, 2001.
4. Pisters KM. Multidisciplinary approach to potentially curable non-small cell carcinoma of the lung. Oncology 11:44,49, 1997.
Other Articles
1. Pisters KMW . Induction chemotherapy in early-stage non-small cell lung cancer. . Curr Oncol Rep 5(4):307-308, 2003. PMID: 12781072.

Book Chapters

1. Ettinger DS, Akerley W, Borghaei H, Chang AC, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Horn L, Jahan TM, Jahanzeb M, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Lennes IT, Loo BW, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pinder-Schenck MC, Pisters KM, Reckamp K, Riely GJ, Rohren E, Swanson SJ, Wood DE, Yang SC, Hughes M, Gregory KM. Non-small cell lung cancer. . In: J Natl Compr Canc Netw. 10, 10. in press, 1236-71, 10/1/2012. ISBN: 23054877.
2. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D'Amico TA, Demmy TL, Ganti AK, Govindan R, Grannis FW, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong FM, Kris MG, Krug LM, Le QT, Lennes IT, Martins R, O'Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ, Rohren E, Simon GR, Swanson SJ, Wood DE, Yang SC, NCCN Non-Small Cell Lung Cancer Panel Members. Non-Small Cell Lung Cancer. In: J Natl Compr Canc Netw. 8, 7. PRR Inc, 740-801, 7/2010. ISBN: 20679538.
3. Pisters KMW . Combined modality therapy of early stage non-small cell lung cancer. In: Respir Care Clin N Am. 9, 2. Saunders, 191-205, 2003. ISBN: 12911289.
4. Vaporciyan, AA, Kelly JF, Pisters KMW. Prevention and management of sequelae of multimodality therapy. In: M. D. Anderson Cancer Series, Lung Cancer. Springer, New York, Inc, 241-255, 2002.
5. Walsh, GL, Pisters KMW, Stevens C. Treatment of stage I lung cancer: The past, present and future. In: Chest Surgery Clinics of North America. 11, 17-38, 2001.
6. Gralla, RJ, Pisters KMW, Kris MG. Chemotherapy-induced nausea and vomiting. In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 735-746, 2000.
7. Pisters KMW. Postoperative adjuvant chemotherapy in non-small cell lung cancer. In: Lung Cancer: Principles and Practice. Lippincott Williams & Wilkins, 769-777, 2000.
8. Pisters, KMW, Kris MG. Prevention of chemotherapy induced nausea and vomiting. In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 689-700, 2000.
9. Pisters, KMW, Kris MG. Chemotherapy-induced nausea and vomiting. . In: Cancer Management: A Multidisciplinary Approach. PRR Inc, 723-734, 1998.
10. Pisters, KMW, Kris MG. Treatment-related nausea and vomiting. . In: Principles and Practice of Supportive Oncology. Lippincott-Raven, 165-178, 1998.
11. Pisters, KMW, Kris MG. Nausea and vomiting. In: Conn’s Current Therapy. W. B. Saunders Company, 48, 1995.
12. Pisters, KMW, Kris MG, Hilaris B, McCormack PM, Bains MS, Gralla RJ, Martini N. Randomized trial of postoperative vindesine and cisplatin in patients with stage III (T1-3N2M0) non-small cell lung cancer. . In: Adjuvant Therapy of Cancer VII. J. B. Lippincott Company, 118-124, 1993.
13. Kris, MG, Tyson LB, Baltzer L, Pisters KMW. Clinical trials in acute cancer chemotherapy-induced vomiting. . In: Mechanisms and Control of Emesis. 223. John Libbey Eurotext Limited, 129-139, 1992.
14. Pisters, KMW, Rivera MP, Kris MG. Acute toxicities of cancer therapy. . In: Critical Care of the Cancer Patient. Mosby Year-Book, Inc., 1-12, 1991.
15. Pisters, KMW, Kris MG. Management of nausea and vomiting caused by anticancer drugs: State of the art. In: Quality of Life in Current Oncology Practice and Research. Dominus Publishing Co, 107-112, 1991.

Letters to the Editor

1. Rice D, Swisher S, Pisters K, Fossella F, Herbst R, Hofstetter W, Kies M, Komaki R, Lippman S, Mehran R, Roth J, Stewart D, Vaporciyan A, Walsh G, Cox J. Comment on "Treatment of non-small cell lung cancer stage IIIA: ACCP evidence-based clinical practice guidelines (2nd edition)". Chest 134(6):1349; author reply 1350, 12/2008. PMID: 19059972.

Last updated: 7/22/2014